A

Aelis Farma SA
PAR:AELIS

Watchlist Manager
Aelis Farma SA
PAR:AELIS
Watchlist
Price: 2.82 EUR -4.73% Market Closed
Market Cap: 38.7m EUR
Have any thoughts about
Aelis Farma SA?
Write Note

Wall Street
Price Targets

AELIS Price Targets Summary
Aelis Farma SA

Wall Street analysts forecast AELIS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AELIS is 9.28 EUR with a low forecast of 4.04 EUR and a high forecast of 14.91 EUR.

Lowest
Price Target
4.04 EUR
43% Upside
Average
Price Target
9.28 EUR
229% Upside
Highest
Price Target
14.91 EUR
429% Upside
Aelis Farma SA Competitors:
Price Targets
COYA
Coya Therapeutics Inc
139% Upside
CDMO
Avid Bioservices Inc
6% Upside
IMRX
Immuneering Corp
422% Upside
XNCR
Xencor Inc
44% Upside
ALERS
Eurobio Scientific SA
19% Upside
TLX
Telix Pharmaceuticals Ltd
17% Upside
INSM
Insmed Inc
23% Upside
CUV
Clinuvel Pharmaceuticals Ltd
107% Upside

Revenue
Forecast

Revenue Estimate
Aelis Farma SA

The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is -29%.

N/A
Past Growth
-29%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aelis Farma SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Aelis Farma SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AELIS's stock price target?
Price Target
9.28 EUR

According to Wall Street analysts, the average 1-year price target for AELIS is 9.28 EUR with a low forecast of 4.04 EUR and a high forecast of 14.91 EUR.

What is Aelis Farma SA's Revenue forecast?
Projected CAGR
-29%

The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is -29%.

Back to Top